Guidelines on Implementing Antimicrobial Stewardship Programs in Korea

키워드

참고문헌 (235)

1. Barlam TF, "Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America", Clin Infect Dis, 62, pp.e51~e77 (2016)
2. "Antimicrobial resistance. Tackling a crisis for the health and wealth of nations"[URL]
3. Society for Healthcare Epidemiology of America, "Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)", Infect Control Hosp Epidemiol, 33, pp.322~327 (2012)
4. Dellit TH, "Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship", Clin Infect Dis, 44, pp.159~177 (2007)
5. : a systematic review, "Antimicrob Resist Infect Control", 2019, 35~
6. Baur D, "Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis", Lancet Infect Dis, 17, pp.990~1001 (2017)
7. 김봉영, "A Survey of Antimicrobial Stewardship Programs in Korea, 2015", Journal of Korean Medical Science, 31(10), pp.1553~1559 (2016), 대한의학회
8. Kim B, "Current status of antimicrobial stewardship programmes in Korean hospitals: results of a 2018nationwide survey", J Hosp Infect, 104, pp.172~180 (2020)
9. Guyatt GH, "Incorporating considerations of resources use into grading recommendations", BMJ, 336, pp.1170~1173 (2008)
10. Rattanaumpawan P, "Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expenditures", Am J Infect Control, 38, pp.38~43 (2010)
11. Feazel LM, "Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis", J Antimicrob Chemother, 69, pp.1748~1754 (2014)
12. Gross R, "Impact of a hospital-based antimicrobial management program on clinical and economic outcomes", Clin Infect Dis, 33, pp.289~295 (2001)
13. Rahal JJ, "Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella", JAMA, 280, pp.1233~1237 (1998)
14. Jang W, "Effect of discontinuation of an antimicrobial stewardship programme on the antibiotic usage pattern", Clin Microbiol Infect (2021)
15. 김혜인, "항생제 스튜어드십 프로그램에 대한 설문조사", 대한내과학회지, 87(2), pp.173~181 (2014), 대한내과학회[DOI]
16. Winters BD, "Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration", J Hosp Med, 5, pp.E41~E45 (2010)
17. Carling P, "Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years", Infect Control Hosp Epidemiol, 24, pp.699~706 (2003)
18. DiazGranados CA, "Prospective audit for antimicrobial stewardship in intensive care: impact on resistance and clinical outcomes", Am J Infect Control, 40, pp.526~529 (2012)
19. Elligsen M, "Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis", Infect Control Hosp Epidemiol, 33, pp.354~361 (2012)
20. Newland JG, "Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children's hospital", J Pediatric Infect Dis Soc, 1, pp.179~186 (2012)
21. Di Pentima MC, "Benefits of a pediatric antimicrobial stewardship program at a children's hospital", Pediatrics, 128, pp.1062~1070 (2011)
22. Lesprit P, "Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial", Clin Microbiol Infect, 19, pp.E91~E97 (2013)
23. Camins BC, "Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial", Infect Control Hosp Epidemiol, 30, pp.931~938 (2009)
24. Masiá M, "Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial", Eur J Clin Microbiol Infect Dis, 27, pp.597~605 (2008)
25. Vettese N, "Outcomes associated with a thrice-weekly antimicrobial stewardship programme in a 253-bed community hospital", J Clin Pharm Ther, 38, pp.401~404 (2013)
26. Liew YX, "Prospective audit and feedback in antimicrobial stewardship: is there value in early reviewing within 48 h of antibiotic prescription?", Int J Antimicrob Agents, 45, pp.168~173 (2015)
27. Davey P, "Interventions to improve antibiotic prescribing practices for hospital inpatients", Cochrane Database Syst Rev, 2 (2017)
28. Mehta JM, "Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship", Infect Control Hosp Epidemiol, 35, pp.1092~1099 (2014)
29. Hurst AL, "Handshake stewardship: A highly effective rounding-based antimicrobial optimization service", Pediatr Infect Dis J, 35, pp.1104~1110 (2016)
30. Doukas FF, "Antimicrobial Stewardship Audit and Feedback rounds: moving beyond the restricted antibiotic list and the impact of electronic systems", Intern Med J (2020)
31. Bantar C, "A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance", Clin Infect Dis, 37, pp.180~186 (2003)
32. Belongia EA, "Emerg Infect Dis", Emerg Infect Dis, 11, pp.912~920 (2005)
33. Landgren FT, "Changing antibiotic prescribing by educational marketing", Med J Aust, 149, pp.595~599 (1988)
34. Abbo LM, "Medical students' perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers?", Clin Infect Dis, 57, pp.631~638 (2013)
35. Marrie TJ, "A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL study investigators. Communityacquired pneumonia intervention trial assessing levofloxacin", JAMA, 283, pp.749~755 (2000)
36. Ibrahim EH, "Experience with a clinical guideline for the treatment of ventilator-associated pneumonia", Crit Care Med, 29, pp.1109~1115 (2001)
37. Schnoor M, "Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia", Qual Saf Health Care, 19, pp.498~502 (2010)
38. Schouten JA, "Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a clusterrandomized, controlled trial", Clin Infect Dis, 44, pp.931~941 (2007)
39. Gulliford MC, "Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care:REDUCE cluster randomised trial", BMJ, 364, pp.1236~ (2019)
40. Cole KA, "Antimicrobial stewardship interventions to combat antibiotic resistance: an update on targeted strategies", Curr Infect Dis Rep, 21, pp.33~ (2019)
41. Chastre J, "Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial", JAMA, 290, pp.2588~2598 (2003)
42. Dimopoulos G, "Shortversus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis", Drugs, 68, pp.1841~1854 (2008)
43. Pugh R, "Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults", Cochrane Database Syst Rev, 2015 (2015)
44. Dimopoulos G, "Short- vs longduration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis", Chest, 144, pp.1759~1767 (2013)
45. Mediwala KN, "Syndrome-specific versus prospective audit and feedback interventions for reducing use of broadspectrum antimicrobial agents", Am J Infect Control, 47, pp.1284~1289 (2019)
46. Patterson PP, "A syndrome-based approach to antimicrobial stewardship in an Arizona skilled nursing facility-Moving the needle through quality improvement", Am J Infect Control, 48, pp.1537~1539 (2020)
47. Haas MK, "Effects of a syndrome-specific antibiotic stewardship intervention for inpatient community-acquired pneumonia", Open Forum Infect Dis, 3, pp.ofw186~ (2016)
48. Omidvari K, "Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis", Respir Med, 92, pp.1032~1039 (1998)
49. Laing RB, "The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards", J Antimicrob Chemother, 42, pp.107~111 (1998)
50. Mertz D, "Outcomes of early switching from intravenous to oral antibiotics on medical wards", J Antimicrob Chemother, 64, pp.188~199 (2009)
51. Siegel RE, "A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy", Chest, 110, pp.965~971 (1996)
52. Oosterheert JJ, "Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial", BMJ, 333, pp.1193~ (2006)
53. 박소미, "Impact of Intervention by an Antimicrobial Stewardship Team on Conversion from Intravenous to Oral Fluoroquinolones", Infection and Chemotherapy, 49(1), pp.31~37 (2017), 대한감염학회
54. Yoon YK, "Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship", PLoS One, 9, pp.e99101~ (2014)
55. Williams P, "Pharmacokinetics", pharmacodynamics of β-lactams and therapeutic drug monitoring: From theory to practical issues in the intensive care unit, 2019, pp.40, 476~487
56. Kemme DJ, "Aminoglycoside dosing: a randomized prospective study", South Med J, 86, pp.46~51 (1993)
57. Fernández de Gatta MD, "Costeffectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies", Clin Pharmacol The, 60, pp.332~340 (1996)
58. Lee YR, "Continuous infusion versus intermittent bolus of beta-lactams in critically ill patients with respiratory infections: A systematic review and metaanalysis", Eur J Drug Metab Pharmacokinet, 43, pp.155~170 (2018)
59. Vardakas KZ, "Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials", Lancet Infect Dis, 18, pp.108~120 (2018)
60. Guilhaumou R, "Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR)", Crit Care, 23, pp.104~ (2019)
61. Coates ARM, "Antibiotic combination therapy against resistant bacterial infections:synergy, rejuvenation and resistance reduction", Expert Rev Anti Infect Ther, 18, pp.5~15 (2020)
62. Harbarth S, "Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis", Am J Med, 115, pp.529~535 (2003)
63. Baddour LM, "Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association", Circulation, 132, pp.1435~1486 (2015)
64. Fernández-Hidalgo N, "Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis", Clin Infect Dis, 56, pp.1261~1268 (2013)
65. Paul M, "Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia", Cochrane Database Syst Rev, (2) (2002)
66. Schmid A, "Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic review and meta-analysis", Sci Rep, 9, pp.15290~ (2019)
67. De Waele JJ, "Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions-a viewpoint of experts", Intensive Care Med, 46, pp.236~244 (2020)
68. Briceland LL, "Antibiotic streamlining from combination therapy to monotherapy utilizing an interdisciplinary approach", Arch Intern Med, 148, pp.2019~2022 (1988)
69. Glowacki RC, "Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance", Clin Infect Dis, 37, pp.59~64 (2003)
70. Paul M, "TREAT Study Group. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial", J Antimicrob Chemother, 58, pp.1238~1245 (2006)
71. Yong MK, "Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system", J Antimicrob Chemother, 65, pp.1062~1069 (2010)
72. Mullett CJ, "Development and impact of a computerized pediatric antiinfective decision support program", Pediatrics, 108, pp.E75~ (2001)
73. Kaushal R, "Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review", Arch Intern Med, 163, pp.1409~1416 (2003)
74. Pestotnik SL, "Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes", Ann Intern Med, 124, pp.884~890 (1996)
75. cGregor JC, "Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial", J Am Med Inform Assoc, 13, pp.378~384 (2006)
76. Bochicchio GV, "Pilot study of a web-based antibiotic decision management guid", J Am Coll Surg, 202, pp.459~467 (2006)
77. Hoff BM, "Implementation of the core elements of antibiotic stewardship in long-term care facilities", J Pathol Inform, 9, pp.10~ (2018)
78. Binkley S, "Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy", Infect Control Hosp Epidemiol, 27, pp.682~687 (2006)
79. Swami SK, "Comparison of hospital-wide and age and location - stratified antibiograms of S. aureus, E. coli, and S. pneumoniae: age- and location-stratified antibiograms", Springerplus, 2, pp.63~ (2013)
80. Kuster SP, "Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay", J Antimicrob Chemother, 62, pp.1451~1461 (2008)
81. Bosso JA, "Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms", Ann Pharmacother, 40, pp.1946~1949 (2006)
82. Anderson DJ, "Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation", Infect Control Hosp Epidemiol, 33, pp.589~593 (2012)
83. Coupat C, "Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a casevignette randomised study", Eur J Clin Microbiol Infect Dis, 32, pp.627~636 (2013)
84. McNulty CA, "Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?", J Antimicrob Chemother, 66, pp.1396~1404 (2011)
85. Tebano G, "Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool", Expert Rev Anti Infect Ther, 18, pp.251~262 (2020)
86. Bonner AB, "Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial", Pediatrics, 112, pp.363~367 (2003)
87. Kadmon G, "Polymerase-chainreaction-based diagnosis of viral pulmonary infections in immunocompromised children", Acta Paediatr, 102, pp.e263~e268 (2013)
88. Peiffer-Smadja N, "Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia", Crit Care, 24, pp.366~ (2020)
89. Huang AM, "Impact of rapid organism identification via matrix-assisted laser desorption", ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia, 2013, pp.57, 1237~1245
90. Bukowski PM, "Implementation of rapid diagnostic testing without active stewardship team notification for Gram-positive blood cultures in a community teaching hospital", Antimicrob Agents Chemother, 62, pp.e01334~e01318 (2018)
91. Avdic E, "Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia", J Antimicrob Chemother, 72, pp.3191~3198 (2017)
92. Banerjee R, "Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing", Clin Infect Dis, 61, pp.1071~1080 (2015)
93. Holtzman C, "Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention", J Clin Microbiol, 49, pp.1581~1582 (2011)
94. Frye AM, "Clinical impact of a realtime PCR assay for rapid identification of staphylococcal bacteremia", J Clin Microbiol, 50, pp.127~133 (2012)
95. Moradi T, "Use of procalcitonin and a respiratory polymerase chain reaction panel to reduce antibiotic use via an electronic medical record alert", Clin Infect Dis, 71, pp.1684~1689 (2020)
96. Roberts C, "Implementation of the core elements of antibiotic stewardship in long-term care facilities", Am J Infect Control, 46(Suppl), pp.S18~S19 (2018)
97. "CDC patient safety portal"[URL]
98. Madaras-Kelly K, Hostler C, Townsend M, Potter EM, Spivak ES, Hall SK, Goetz MB, Nevers M, Ying J, Haaland B, Rovelsky SA, Pontefract B, Fleming-Dutra K, Hicks LA, Samore MH, "Impact of implementation of the core elements of outpatient antibiotic stewardship within veterans health administration emergency departments and primary care clinics on antibiotic prescribing and patient outcomes", Clin Infect Dis, 73, pp.e1126~e1134 (2021)
99. Bernard SR, "Association between meeting core elements for inpatient antimicrobial stewardship and antibiotic utilization", Infect Control Hosp Epidemiol, 40, pp.1050~1052 (2019)
100. Karanika S, "Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs", Antimicrob Agents Chemother, 60, pp.4840~4852 (2016)
101. Cunha CB, "The pharmacoeconomic aspects of antibiotic stewardship programs", Med Clin North Am, 102, pp.937~946 (2018)
102. Nhan D, "Structure of antimicrobial stewardship programs in leading US hospitals: Findings of a nationwide survey", Open Forum Infect Dis, 6, pp.ofz104~ (2019)
103. Heil EL, "The essential role of pharmacists in antimicrobial stewardship", Infect Control Hosp Epidemiol, 37, pp.753~754 (2016)
104. "AUR vendors"[URL]
105. "ATC/DDD Index 2021"[URL]
106. Ostrowsky B, "Infectious diseases physicians:leading the way in antimicrobial stewardship", Clin Infect Dis, 66, pp.995~1003 (2018)
107. Fishman N, "Antimicrobial stewardship", Am J Med, 119(6 Suppl 1), pp.S53~S61 (2006)
108. 장영은, "Infectious Diseases Physician Workforce in Korea", Journal of Korean Medical Science, 35(49), pp.1~6 (2020), 대한의학회[DOI]
109. Parente DM, "Role of the pharmacist in antimicrobial stewardship", Med Clin North Am, 102, pp.929~936 (2018)
110. Ourghanlian C, "Pharmacists' role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre study", J Glob Antimicrob Resist, 20, pp.131~134 (2020)
111. 김형숙, "항균제 관리팀에서 약사의 업무 개발 및 확대 방안", 병원약사회지, 35(1), pp.30~38 (2018), 한국병원약사회[DOI]
112. 최지나, "약사의 외상중환자실 팀 활동 참여 전후의 항생제 및 영양지원 적절성 평가", 병원약사회지, 38(1), pp.65~74 (2021), 한국병원약사회[DOI]
113. Olans RD, "Nurses and antimicrobial stewardship: Past, present, and future", Infect Dis Clin North Am, 4, pp.67~82 (2020)
114. Adre C, "Recommendations for improving antimicrobial stewardship in long-term care settings through collaboration", Infect Dis Clin North Am, 34, pp.129~143 (2020)
115. Palavecino EL, "Collaborative antimicrobial stewardship: Working with microbiology", Infect Dis Clin North Am, 34, pp.51~65 (2020)
116. Gentry EM, "Bugs and drugs: collaboration between infection prevention and antibiotic stewardship", Infect Dis Clin North Am, 34, pp.17~30 (2020)
117. Kuper KM, "Collaborative antimicrobial stewardship: Working with information technology", Infect Dis Clin North Am, 3, pp.31~49 (2020)
118. van Daalen FV, "The economic evaluation of an antibiotic checklist as antimicrobial stewardship intervention", J Antimicrob Chemother, 72, pp.3213~3221 (2017)
119. Suzuki H, "Inpatient fluoroquinolone stewardship improves the quantity and quality of fluoroquinolone prescribing at hospital discharge: a retrospective analysis among 122 veterans health administration hospitals", Clin Infect Dis, 71, pp.1232~1239 (2020)
120. Singh S, "Implementation and impact of an antimicrobial stewardship program at a tertiary care center in South India", Open Forum Infect Dis, 6, pp.ofy290~ (2018)
121. Loo LW, "Discontinuation of antibiotic therapy within 24hours of treatment initiation for patients with no clinical evidence of bacterial infection: a 5-year safety and outcome study from Singapore general hospital antimicrobial stewardship program", Int J Antimicrob Agents, 53, pp.606~611 (2019)
122. García-Rodríguez JF, "Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact", Eur J Clin Microbiol Infect Dis, 38, pp.161~170 (2019)
123. Al-Omari A, "The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis", Antimicrob Resist Infect Control, 9, pp.95~ (2020)
124. Nilholm H, "An audit-based, infectious disease specialist-guided antimicrobial stewardship program profoundly reduced antibiotic use without negatively affecting patient outcomes", Open Forum Infect Dis, 2, pp.ofv042~ (2015)
125. Libertin CR, "Dramatic effects of a new antimicrobial stewardship program in a rural community hospital", Am J Infect Control, 45, pp.979~982 (2017)
126. Taggart LR, "Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study", BMC Infect Dis, 15, pp.480~ (2015)
127. Honda H, "Efficacy of a postprescription review of broad-spectrum antimicrobial agents with feedback: A 4-year experience of antimicrobial stewardship at a tertiary care center", Open Forum Infect Dis, 5, pp.ofy314~ (2018)
128. Akazawa T, "Eight-year experience of antimicrobial stewardship program and the trend of carbapenem use at a tertiary acute-care hospital in Japan-The impact of postprescription review and feedback", Open Forum Infect Dis, 6, pp.ofz389~ (2019)
129. Choe PG, "Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence", BMC Infect Dis, 18, pp.178~ (2018)
130. Palmay L, "Hospital-wide rollout of antimicrobial stewardship: a stepped-wedge randomized trial", Clin Infect Dis, 59, pp.867~874 (2014)
131. Zhou H, "PP207 evaluation on effects of antimicrobial stewardship in tertiary comprehensive public hospitals in Hainan, China", Int J Technol Assess Health Care, 35(Suppl 1), pp.74~ (2019)
132. Kim M, "Redundant combinations of antianaerobic antimicrobials: impact of pharmacistbased prospective audit and feedback and prescription characteristics", Eur J Clin Microbiol Infect Dis, 39, pp.75~83 (2020)
133. Hwang H, "Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital", Sci Rep, 8, pp.14757~ (2018)
134. Kim YC, "Impact of an infectious disease specialist on an antimicrobial stewardship program at a resource-limited, nonacademic community hospital in Korea", J Clin Med, 8, pp.1293~ (2019)
135. Lee RA, "Improvement of gram-negative susceptibility to fluoroquinolones after implementation of a preauthorization policy for fluoroquinolone use: A decade-long experience", Infect Control Hosp Epidemiol, 39, pp.1419~1424 (2018)
136. Lee TC, "Antibiotic self-stewardship: trainee-led structured antibiotic time-outs to improve antimicrobial use", Ann Intern Med, 161(10 Suppl), pp.S53~S58 (2014)
137. Huh K, "Impact of monitoring surgical prophylactic antibiotics and a computerized decision support system on antimicrobial use and antimicrobial resistance", Am J Infect Control, 44, pp.e145~e152 (2016)
138. Fernández-Urrusuno R, "Successful improvement of antibiotic prescribing at primary care in Andalusia following the implementation of an antimicrobial guide through multifaceted interventions: An interrupted time-series analysis", PLoS One, 15, pp.e0233062~ (2020)
139. Shively NR, "Impact of a telehealth-based antimicrobial stewardship program in a community hospital health system", Clin Infect Dis, 71, pp.539~545 (2020)
140. MacBrayne CE, "Sustainability of handshake stewardship: extending a hand is effective years later", Clin Infect Dis, 70, pp.2325~2332 (2020)
141. Dyar OJ, "What is antimicrobial stewardship?", Clin Microbiol Infect, 23, pp.793~798 (2017)
142. Gonzales R, "Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background", Ann Emerg Med, 37, pp.720~727 (2001)
143. Ibrahim EH, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting", Chest, 118, pp.146~155 (2000)
144. Wang A, "Evaluating the relationship between hospital antibiotic use and antibiotic resistance in common nosocomial pathogens", Infect Control Hosp Epidemiol, 38, pp.1457~1463 (2017)
145. Kumar A, "Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock", Chest, 136, pp.1237~1248 (2009)
146. Shorr AF, "Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay", Crit Care Med, 39, pp.46~51 (2011)
147. Patel D, "Antimicrobial stewardship programs: interventions and associated outcomes", Expert Rev Anti Infect Ther, 6, pp.209~222 (2008)
148. Tamma PD, "Antimicrobial stewardship: another focus for patient safety?", Curr Opin Infect Dis, 27, pp.348~355 (2014)
149. Burston J, "A role for antimicrobial stewardship in clinical sepsis pathways: a prospective interventional study", nfect Control Hosp Epidemiol, 38, pp.1032~1038 (2017)
150. Masterton RG, "Antibiotic de-escalation", Crit Care Clin, 27, pp.149~162 (2011)
151. Yamada K, "The intervention by an antimicrobial stewardship team can improve clinical and microbiological outcomes of resistant gramnegative bacteria", J Infect Chemother, 25, pp.1001~1006 (2019)
152. Seah VXF, "Impact of a carbapenem antimicrobial stewardship program on patient outcomes", Antimicrob Agents Chemother, 61, pp.e00736~e00717 (2017)
153. Morrill HJ, "Antimicrobial stewardship program prompts increased and earlier infectious diseases consultation", Antimicrob Resist Infect Control, 3, pp.12~ (2014)
154. Rimawi RH, "Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome", Crit Care Med, 41, pp.2099~2107 (2013)
155. Schmitt S, "Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs", Clin Infect Dis, 58, pp.22~28 (2014)
156. Lee CF, "Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis", J Antimicrob Chemother, 73, pp.844~851 (2018)
157. Schuts EC, "Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis", Lancet Infect Dis, 16, pp.847~856 (2016)
158. Ng TM, "Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team", Int J Antimicrob Agents, 50, pp.166~170 (2017)
159. Adhikari S, "Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis", Int J Antimicrob Agents, 51, pp.620~628 (2018)
160. Nowak MA, "Clinical and economic outcomes of a prospective antimicrobial stewardship program", Am J Health Syst Pharm, 69, pp.1500~1508 (2012)
161. Honda H, "Antimicrobial stewardship in inpatient settings in the Asia Pacific region: A systematic review and meta-analysis", Clin Infect Dis, 64(S119-26.), pp.S119~S126 (2017)
162. Rüttimann S, "Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital", Clin Infect Dis, 38, pp.348~356 (2004)
163. Malani AN, "Clinical and economic outcomes from a community hospital's antimicrobial stewardship program", Am J Infect Control, 41, pp.145~148 (2013)
164. Tsai D, "Pharmacokinetic", pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill, 2015, pp.21, 412~420
165. Roberts JA, "Using PK", PD to optimize antibiotic dosing for critically ill patients, 2011, pp.12, 2070~2079
166. Bennett JE, "Mandell, Douglas, and Bennett's principles and practice of infectious diseases" (2014), Saunders
167. Bruno-Murtha LA, "A pilot study of antibiotic cycling in the community hospital setting", Infect Control Hosp Epidemiol, 26, pp.81~87 (2005)
168. Ingram PR, "Point-prevalence study of inappropriate antibiotic use at a tertiary Australian hospital", Intern Med J, 42, pp.719~721 (2012)
169. Zahar JR, "Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team", J Antimicrob Chemother, 58, pp.651~656 (2006)
170. Suh Y, "Potential impact of the involvement of clinical pharmacists in antimicrobial stewardship programs on the incidence of antimicrobial-related adverse events in hospitalized patients: A multicenter retrospective study", Antibiotics (Basel), 10, pp.853~ (2021)
171. Leehey DJ, "Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy", J Am Soc Nephrol, 4, pp.81~90 (1993)
172. Bartal C, "Pharmacokinetic dosing of aminoglycosides: a controlled trial", Am J Med, 114, pp.194~198 (2003)
173. Freeman CD, "Mega-analysis of meta-analysis: an examination of meta-analysis with an emphasis on once-daily aminoglycoside comparative trials", Pharmacotherapy, 16, pp.1093~1102 (1996)
174. Barza M, "Single or multiple daily doses of aminoglycosides: a metaanalysis", BMJ, 312, pp.338~345 (1996)
175. Cataldo MA, "Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis", J Antimicrob Chemother, 67, pp.17~24 (2012)
176. Gerding DN, "Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea:this is an antimicrobial resistance problem", Clin Infect Dis, 38, pp.646~648 (2004)
177. Climo MW, "Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost", Ann Intern Med, 128, pp.989~995 (1998)
178. Valiquette L, "Impact of a reduction in the use of highrisk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1", 027 strain, 2007, pp.45(Suppl 2), S112~S121
179. Aldeyab MA, "An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings", J Antimicrob Chemother, 67, pp.2988~2996 (2012)
180. Talpaert MJ, "Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection", J Antimicrob Chemother, 66, pp.2168~2174 (2011)
181. Dancer SJ, "Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus", Int J Antimicrob Agents, 41, pp.137~142 (2013)
182. Price J, "Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis", Clin Microbiol Infect, 16, pp.1297~1302 (2010)
183. Fowler S, "Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series", J Antimicrob Chemother, 59, pp.990~995 (2007)
184. Kallen AJ, "Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital", Infect Control Hosp Epidemiol, 30, pp.264~272 (2009)
185. Macy E, "Health care use and serious infection prevalence associated with penicillin “allergy”in hospitalized patients: A cohort study", J Allergy Clin Immunol, 133, pp.790~796 (2014)
186. Unger NR, "Penicillin skin testing: potential implications for antimicrobial stewardship", Pharmacotherapy, 33, pp.856~867 (2013)
187. ark MA, "Diagnosis and management of penicillin allergy", Mayo Clin Proc, 80, pp.405~410 (2005)
188. Trubiano J, "Antimicrobial stewardship's new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’", Curr Opin Infect Dis, 26, pp.526~537 (2013)
189. Krishna MT, "Enhancing antibiotic stewardship by tackling “spurious” penicillin allergy", Clin Exp Allergy, 47, pp.1362~1373 (2017)
190. Rimawi RH, "The impact of penicillin skin testing on clinical practice and antimicrobial stewardship", J Hosp Med, 8, pp.341~345 (2013)
191. Park MA, "Collaboration between allergists and pharmacists increases β-lactam antibiotic prescriptions in patients with a history of penicillin allergy", Int Arch Allergy Immunol, 154, pp.57~62 (2011)
192. Owens RC Jr, "Antimicrobial stewardship: shepherding precious resources", Am J Health Syst Pharm, 66(2 Suppl 4), pp.S15~S22 (2009)
193. Roberts RR, "Hospital and societal costs of antimicrobialresistant infections in a Chicago teaching hospital: implications for antibiotic stewardship", Clin Infect Dis, 49, pp.1175~1184 (2009)
194. Rupnik M, "Clostridium difficile infection: new developments in epidemiology and pathogenesis", Nat Rev Microbiol, 7, pp.526~536 (2009)
195. Lucado J, Gould C, Elixhauser A, "Healthcare Cost and Utilization Project (HCUP) Statistical Briefs" (2006), Agency for Healthcare Research and Quality
196. Savoldi A, "Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study", Sci Rep, 10, pp.8194~ (2020)
197. Pulcini C, "Antimicrobial stewardship in emergency departments: a neglected topic", Emerg Med J, 32, pp.506~ (2015)
198. Trinh TD, "Antimicrobial Stewardship in the Emergency Department", Infect Dis Ther, 4(Suppl 1), pp.39~50 (2015)
199. Mistry RD, "Current state of antimicrobial stewardship in children's hospital emergency departments", Infect Control Hosp Epidemiol, 38, pp.469~475 (2017)
200. Davey P, "Interventions to improve antibiotic prescribing practices for hospital inpatients", Cochrane Database Syst Rev (2013)
201. Forster AJ, "The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital", CMAJ, 184, pp.37~42 (2012)
202. Tacconelli E, "Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital populationbased study", Antimicrob Agents Chemother, 53, pp.4264~4269 (2009)
203. Tacconelli E, "Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis", J Antimicrob Chemothe, 61, pp.26~38 (2008)
204. Tinelli M, "Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities", J Antimicrob Chemother, 67, pp.2982~2987 (2012)
205. 박선희, "의료기관에서의 다제내성균 관리", 대한의사협회지, 61(1), pp.26~35 (2018), 대한의사협회[DOI]
206. Cisneros JM, "Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre", Clin Microbiol Infect, 20, pp.82~88 (2014)
207. Molina J, "Long-term impact of an educational antimicrobial stewardship program on hospital-acquired candidemia and multidrug-resistant bloodstream infections:A quasi-experimental study of interrupted time-series analysis", Clin Infect Dis, 65, pp.1992~1999 (2017)
208. Webb BJ, "Antimicrobial stewardship in a hematological malignancy unit: carbapenem reduction and decreased vancomycin-resistant Enterococcus infection", Clin Infect Dis, 71, pp.960~967 (2020)
209. Teerawattanapong N, "Prevention and control of multidrug-resistant Gram-negative bacteria in adult intensive care units: A systematic review and network meta-analysis", Clin Infect Dis, 64(suppl_2), pp.S51~S60 (2017)
210. Bertollo LG, "Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review", Am J Infect Control, 46, pp.824~836 (2018)
211. Chatzopoulou M, "Role of antimicrobial restrictions in bacterial resistance control: a systematic literature review", J Hosp Infect, 104, pp.125~136 (2020)
212. Lautenbach E, "Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins", Clin Infect Dis, 36, pp.440~446 (2003)
213. Quale J, "Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci", qClin Infect Dis, 23, pp.1020~1025 (1996)
214. Rodriguez-Osorio CA, "Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study", J Antimicrob Chemother, 70, pp.914~921 (2015)
215. Ma X, "Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center.", BMC Infect Dis, 16, pp.704~ (2016)
216. Lai CC, "Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison", J Microbiol Immunol Infect, 49, pp.74~82 (2016)
217. Buckel WR, "Antimicrobial stewardship in community hospitals", Med Clin North Am, 102, pp.913~928 (2018)
218. Smith T, "Antimicrobial stewardship in a community hospital: attacking the more difficult problems", Hosp Pharm, 49, pp.839~846 (2014)
219. Gavazzi G, "Ageing and infection", Lancet Infect Dis, 2, pp.659~666 (2002)
220. Tandan M, "A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016", Euro Surveill, 24, pp.1800102~ (2019)
221. Dyar OJ, "Strategies and challenges of antimicrobial stewardship in long-term care facilities", Clin Microbiol Infect, 21, pp.10~19 (2015)
222. Nicolle LE, "Antimicrobial use in long-term-care facilities", Infect Control Hosp Epidemiol, 21, pp.537~545 (2000)
223. van Buul LW, "Antibiotic use and resistance in long term care facilities", J Am Med Dir Assoc, 13, pp.568.e1~568.e13 (2012)
224. Ford PJ, "Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients", Bioethics, 19, pp.379~392 (2005)
225. Smith PW, "SHEA", APIC guideline: Infection prevention and control in the long-term care facility, 2008, pp.36, 504~535
226. Chambers A, "A recipe for antimicrobial stewardship success: Using intervention mapping to develop a program to reduce antibiotic overuse in long-term care", Infect Control Hosp Epidemiol, 40, pp.24~31 (2019)
227. Daneman N, "Antibiotic use in long-term care facilities", J Antimicrob Chemother, 66, pp.2856~2863 (2011)
228. Zabarsky TF, "Sustained reduction in inappropriate treatment of asymptomatic bacteriuria in a long-term care facility through an educational intervention", Am J Infect Control, 36, pp.476~480 (2008)
229. M'ikanatha NM, "Implementation of antimicrobial stewardship and infection prevention and control practices in long-term care facilities-Pennsylvania, 2017", Infect Control Hosp Epidemiol, 40, pp.713~716 (2019)
230. Stenehjem E, "Impact of implementing antibiotic stewardship programs in 15 small hospitals: A cluster-randomized intervention", Clin Infect Dis, 67, pp.525~532 (2018)
231. Lee MJ, "Status of antimicrobial stewardship programmes in Korean hospitals including small to medium-sized hospitals and the awareness and demands of physicians: a nationwide survey in 2020", J Glob Antimicrob Resist, 26, pp.180~187 (2021)
232. Bartlett JM, "Implementation and first-year results of an antimicrobial stewardship program at a community hospital", Am J Health Syst Pharm, 71, pp.943~949 (2014)
233. Stevenson LD, "A pilot study using telehealth to implement antimicrobial stewardship at two rural Veterans Affairs medical centers", Infect Control Hosp Epidemiol, 39, pp.1163~1169 (2018)
234. Beaulac K, "Antimicrobial Stewardship in a Long-term acute care hospital using offsite electronic medical record audit.", Infect Control Hosp Epidemiol, 37, pp.433~439 (2016)
235. Lawes T, "Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis", Lancet Infect Dis, 17, pp.194~206 (2017)

관련 논문AI추천